Skip to main content
. 2018 May 4;9:823. doi: 10.3389/fmicb.2018.00823

Table 1.

Antibiotic susceptibility profile of clinical Enterobacter cloacae isolates.

Strains Resistant (R) Susceptible (S) Intermediate (I)
EspIMS6 CZX, CX, LE, CTR, TCC, PIT, GAT, A/S, CTX, AMC, OF, CIP, AMP, CXM, IPM, CPM, COT, CAZ, CAC, AT GEN, AK MRP
ATCC 13047 AMC, CXM, AMP, CAZ, CX, CAC, A/S COT, CPM, IPM, CIP, GEN, GAT, AT, OF, AK, MRP, PIT, CZX, LE CTR, CTX

Antibiotic resistance profile of EspIMS6 and E. cloacae type strain ATCC 13047 control using DoDeca Enterobacteriaceae disks 1 and 2 (Himedia, India). Disk 1: Ampicillin-AMP (10 mcg), Gentamicin-GEN (10 mcg), Amikacin-AK (30 mcg), Ciprofloxacin-CIP (5 mcg), Ofloxacin-OF (5 mcg), Co-Trimoxazole-COT (25 mcg), Amoxyclav-AMC (30 mcg), Cefuroxime-CXM (30 mcg), Ceftazidime-CAZ (30 mcg), Ceftazidime/Clavulanic acid-CAC (30/10 mcg), Cefepime-CPM (30 mcg), Imipenem-IPM (10 mcg). Disk 2: Cefotaxime-CTX (30 mcg), Cetriaxone-CTR (30 mcg), Cefoxitin-CX (30 mcg), Meropenem-MRP (10 mcg), Piperacillin/Tazobactam-PIT (100/10 mcg), Aztreonam-AT (30 mcg), Gatifloxacin-GAT (5 mcg), Ampicillin/Sulbactam-A/S (10/10 mcg), Cefoperazone-CPZ (75 mcg), Levofloxacin-LE (5 mcg), Ceftizoxime-CZX (30 mcg), Ticarcillin/Clavulanic acid-TCC (75/10 mcg).